blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1618876

EP1618876 - Use of sphingolipids for prevention and treatment of atherosclerosis [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.03.2007
Database last updated on 20.09.2024
Most recent event   Tooltip09.03.2007Application deemed to be withdrawnpublished on 11.04.2007  [2007/15]
Applicant(s)For all designated states
Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO
Anna van Buerenplein 1
2595 DA 's-Gravenhage / NL
[N/P]
Former [2006/04]For all designated states
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Onderzoek TNO
Schoemakerstraat 97
2628 VK Delft / NL
Inventor(s)01 / Nieuwenhuizen, Willem Ferdinand
Provincialeweg 61A
3981 AM Bunnik / NL
02 / Emeis, Josephus Jan
Hoogte Kadijk 37C
1018 BE Amsterdam / NL
03 / Havekes, Aloysius Maria
Lokhorst 9
2402 PP Alphen aan den Rijn / NL
 [2006/04]
Representative(s)Winckels, Johannes Hubertus F., et al
Vereenigde
Johan de Wittlaan 7
2517 JR Den Haag / NL
[N/P]
Former [2006/04]Winckels, Johannes Hubertus F., et al
Vereenigde Johan de Wittlaan 7
2517 JR Den Haag / NL
Application number, filing date04077091.919.07.2004
[2006/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1618876
Date:25.01.2006
Language:EN
[2006/04]
Search report(s)(Supplementary) European search report - dispatched on:EP05.01.2005
ClassificationIPC:A61K31/133, A61K31/688, A23J7/00, A23L1/30, A61P9/10
[2006/04]
CPC:
A61K31/133 (EP,US); A61K31/688 (EP,US); A61P17/06 (EP);
A61P37/00 (EP); A61P9/10 (EP)
Designated contracting states(deleted) [2006/39]
Former [2006/04]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Verwendung von Sphingolipiden zur Vorbeugung und Behandlung von Atherosklerose[2006/04]
English:Use of sphingolipids for prevention and treatment of atherosclerosis[2006/04]
French:Utilisation de sphingolipides pour la prévention et le traitement de l'athérosclérose[2006/04]
Examination procedure26.07.2006Application deemed to be withdrawn, date of legal effect  [2007/15]
17.11.2006Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2007/15]
Fees paidPenalty fee
Penalty fee Rule 85a EPC 1973
31.08.2006AT   M01   Not yet paid
31.08.2006BE   M01   Not yet paid
31.08.2006BG   M01   Not yet paid
31.08.2006CH   M01   Not yet paid
31.08.2006CY   M01   Not yet paid
31.08.2006CZ   M01   Not yet paid
31.08.2006DE   M01   Not yet paid
31.08.2006DK   M01   Not yet paid
31.08.2006EE   M01   Not yet paid
31.08.2006ES   M01   Not yet paid
31.08.2006FI   M01   Not yet paid
31.08.2006FR   M01   Not yet paid
31.08.2006GB   M01   Not yet paid
31.08.2006GR   M01   Not yet paid
31.08.2006HU   M01   Not yet paid
31.08.2006IE   M01   Not yet paid
31.08.2006IT   M01   Not yet paid
31.08.2006LU   M01   Not yet paid
31.08.2006MC   M01   Not yet paid
31.08.2006NL   M01   Not yet paid
31.08.2006PL   M01   Not yet paid
31.08.2006PT   M01   Not yet paid
31.08.2006RO   M01   Not yet paid
31.08.2006SE   M01   Not yet paid
31.08.2006SI   M01   Not yet paid
31.08.2006SK   M01   Not yet paid
31.08.2006TR   M01   Not yet paid
Penalty fee Rule 85b EPC 1973
31.08.2006M01   Not yet paid
Additional fee for renewal fee
31.07.200603   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]JPS6344842  ;
 [XY]KR20010008569  ;
 [XY]JP2003137894  ;
 [XY]WO9203129  (UNIV DUKE [US]) [X] 1,7,10 * page 3, line 29 - page 4, line 28 * * page 8, line 14 - line 17 * * page 9, line 29 - page 10, line 8 * * page 12, line 11 - line 15 * * page 13, line 11 - line 20 * [Y] 6,8,9;
 [XY]US5190876  (MERRILL JR ALFRED H [US], et al) [X] 1,2,4,7,10 * column 1, line 66 - column 2, line 9 * * claims 1,4,6 * [Y] 6,8,9;
 [DXY]WO9941266  (UNIV EMORY [US], et al) [DX] 1-4,7,10 * page 13, line 3 - line 17 * * page 61, line 10 - page 62, line 13 * * page 83, line 10 - line 23 * * claims 3,19,32 * * figure 7; compounds 17A,B * * figure 9; compound 27 * [Y] 6,8,9;
 [XY]WO9961581  (DEAN OF RESEARCH AND GRADUATE [US], et al) [X] 1,2,4,7,10 * page 36, line 14 - line 21 * [Y] 6,8,9;
 [XY]WO0050574  (UNIV JOHNS HOPKINS [US]) [X] 1,3,7,10 * page 1, line 12 - line 19 * * page 6, line 13 - page 8, line 12 * * page 16, line 9 - line 14 * * page 19, line 11 - line 18 * * claims 1,2,8-10,28,29,31-33,35-39,41,45-48 * [Y] 6,8,9;
 [Y]WO0234062  (MARC BOONE NV [BE], et al) [Y] 6,8,9 * page 4, line 9 - line 18 * * claims 1,7,8 *;
 [XY]US2003109044  (LOGAN THOMAS JOSEPH [US], et al) [X] 1,3,7,10 * page 1, paragraph 6 * * page 2, paragraphs 23,24,26 * * page 38, paragraph 438 * [Y] 6,8,9;
 [XY]US2004047851  (TABAS IRA [US], et al) [X] 1,3,7,10 * page 4, paragraph 32 * * page 5, paragraphs 35,36,39 * * page 6, paragraph 51 * * claims 1,3,4,14-16 * [Y] 6,8,9;
 [E]WO2004064823  (UNIV ASTON [GB], et al) [E] 1,7,10 * page 2, paragraph 3 - page 3, paragraph 5 * * page 6, paragraph 1 * * claims 1,2,10-12 *;
 [E]WO2004064820  (TNO [NL], et al) [E] 1-10 * page 1, lines 3-9,18-25 * * page 2, line 4 - line 26 * * page 4, lines 8,9 * * page 5, line 11 - page 7, line 12 * * page 9, line 8 - line 16 * * page 16, lines 1-4 * * page 19, line 14 - line 23 ** claim - *;
 [E]EP1452181  (ENZO THERAPEUTICS INC [US]) [E] 1,7,10 * column 1, paragraph 1 * * column 9, paragraphs 35,37 * * column 10, paragraph 43 * * claims 1,7-10,15 *;
 [E]WO2004096140  (PENN STATE RES FOUND [US], et al) [E] 1,7,10 * page 9, paragraphs 44-46 *;
 [A]  - M.H. BEERS, R. BERKOW, The Merck Manual of Diagnosis and Therapy, seventeenth edition, WHITEHOUSE STATION, N.J., MERCK RESEARCH LABORATORIES, (1999), XP002311213 [A] * page 1654 - page 1658 *
 [XY]  - MURATA SHOICHI, HARA KENJI, "O/W/O-type emulsified oil and fat composition", DATABASE WPI, 0, Derwent World Patents Index, (19880225), no. 19, Database accession no. 1988-094775, page 4, XP002311214 & JPS6344842 A 19880225 (KAO CORP.) [X] 1,3,7,10 * column A * [Y] 6,8,9
 [XY]  - KIM G.W. ET AL., "Angiogenesis promotor containing sphingosine-1-phosphate as active ingredient", DATABASE WPI, 0, Derwent World Patents Index, (20020624), no. 20, Database accession no. 2001-473283, page 1, XP002311215 & KR20010008569 A 20010205 (KWON Y G) [X] 1,7,10 * column A * [Y] 6,8,9
 [XY]  - TAMAI TADAKAZU ET AL., "Phosphorylated amino alcohol, method of producing the same and use thereof", DATABASE WPI, 0, Derwent World Patents Index, (20030514), no. 20, Database accession no. 2003-692298, page 6, XP002311216 & JP2003137894 A 20030514 (NAT. INST. OF ADV. IND. & TECHNOL.; MARUHA CORP.) [X] 1,7,10 * column A * [Y] 6,8,9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.